EVEREST-1: Safety and efficacy data of A2B530, a logic-gated Tmod chimeric antigen receptor T-cell (CAR T) therapy, in patients with solid tumors associated with carcinoembryonic antigen (CEA) expression and with human leukocyte antigen (HLA) loss of heterozygosity (LOH).

Julian  Molina

No Relationships to Disclose

Patrick  Grierson

Employment - Walgreens (I)

Honoraria - AstraZeneca

Consulting or Advisory Role - AstraZeneca

Patents, Royalties, Other Intellectual Property - Compositions and Methods for the Treatment of Pancreatic Cancer

Joel  Hecht

Stock and Other Ownership Interests  - Actym Therapeutics; Rafael Pharmaceuticals; Trumvira

Consulting or Advisory Role - Agenus; Astellas Pharma; BeiGene; Bristol-Myers Squibb/Medarex; Galvanize Therapeutics; MBQ Pharma; Revolution Medicines; Taiho Pharmaceutical; Xilio Therapeutics

Research Funding - A2 Biotherapeutics (Inst); Affini-T Therapeutics (Inst); Agenus (Inst); Amgen (Inst); Bold Therapeutics (Inst); Camurus (Inst); Cardiff Oncology (Inst); CG Pharmaceuticals (Inst); Crinetics Pharmaceuticals (Inst); Exelixis (Inst); Gilead Sciences (Inst); Gritstone Bio (Inst); Janssen Oncology (Inst); Lyell Immunopharma (Inst); Merck (Inst); Mirati Therapeutics (Inst); Neogene Therapeutics (Inst); NGM Biopharmaceuticals (Inst); Regeneron (Inst); Revolution Medicines (Inst); Seagen (Inst); Tizona Therapeutics, Inc. (Inst); Tizona Therapeutics, Inc. (Inst); Xilio Therapeutics (Inst)

Sandip  Patel

Consulting or Advisory Role - Amgen; AstraZeneca/MedImmune; BeiGene; Bristol-Myers Squibb; Certis Oncology Solutions; Compugen; Illumina; Iovance Biotherapeutics (Inst); Lilly; Lilly; Merck; Nektar; Novartis; Pfizer; Roche/Genentech; Tempus

Speakers' Bureau - Boehringer Ingelheim; Merck

Research Funding - Amgen (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Fate Therapeutics (Inst); Iovance Biotherapeutics (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Rubius Therapeutics; Takeda (Inst); Takeda (Inst)

Diane  Simeone

Leadership - Immodulon; Immunovia

Stock and Other Ownership Interests  - Longevity Life Advisors

Honoraria - Pfizer

Consulting or Advisory Role - FibroGen

Research Funding - Biological Dynamics; Clearnote Health; Immunovia; Micronoma

Patents, Royalties, Other Intellectual Property - small royalties for my patent on pancreatic cancer stem cells also I receive an annual royalty for a textbook I edited Greenfields Textbook of Surgery

Theodore  Welling

No Relationships to Disclose

Kedar  Kirtane

Leadership - MyCareGorithm

Stock and Other Ownership Interests  - Agenus; Oncternal Therapeutics; Veru

Consulting or Advisory Role - MyCareGorithm

Research Funding - Turnstone Bio

Travel, Accommodations, Expenses - A2Bio

Maria Pia  Morelli

No Relationships to Disclose

Madappa  Kundranda

Consulting or Advisory Role - AstraZeneca; Bayer; Boston Scientific; BPG Bio; Bristol-Myers Squibb; Genomic Health; STERIS

Research Funding - Bayer (Inst); Celgene; Chronix Biomedical (Inst)

David  Maloney

Stock and Other Ownership Interests  - A2 Biotherapeutics

Honoraria - A2 Biotherapeutics; Bristol-Myers Squibb/Celgene; Genentech/Roche; Gilead Sciences; Kite, a Gilead company; Lyell Immunopharma; Novartis; Umoja Biopharma

Consulting or Advisory Role - A2 Biotherapeutics; Celgene/Bristol-Myers Squibb; Genentech; NAVAN Technologies

Research Funding - Celgene (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst)

Patents, Royalties, Other Intellectual Property - Inventor on 4 provisional patents.

Frederick  Locke

Consulting or Advisory Role - A2 Biotherapeutics; Alimera Sciences; Amgen; Bluebird Bio; Bristol-Myers Squibb; Bristol-Myers Squibb/Celgene; Calibr; Caribou Biosciences; Celgene; Cowen; Daiichi Sankyo/UCB Japan; EcoR1 Capital; Gerson Lehrman Group; Iovance Biotherapeutics; Janssen; Kite, a Gilead company; Legend Biotech; Miltenyi Biotec; Novartis; Sana Biotechnology; Takeda; Takeda; Umoja Biopharma

Research Funding - Alimera Sciences (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb/Celgene (Inst); Kite, a Gilead company (Inst); Novartis (Inst)

Patents, Royalties, Other Intellectual Property - CAR T Cells with Enhanced Metabolic Fitness. Serial Number: 62/939,727 (Inst); Double Mutant Survivin Vaccine. US010414810B2. (Inst); Evolutionary Dynamics of Non-Hodgkin Lymphoma CAR-T cell therapy. Serial Number: 62/879,534. (Inst); Methods of Enhancing CAR T Cell Therapies. Serial Number: 62/892,292. (Inst)

Travel, Accommodations, Expenses - A2 Biotherapeutics; Kite, a Gilead company

Marcela  Maus

Leadership - 2seventy bio

Stock and Other Ownership Interests  - 2seventy bio; A2Bio; Affyimumune; BendBio; CARGO Therapeutics; GBM newco; Model T Bio; NexImmune; Oncternal Therapeutics

Consulting or Advisory Role - Adaptimmune; AffyImmune Therapeutics; Agenus; arcellx; Astellas Pharma; AstraZeneca; Atara Biotherapeutics; Bayer; BMS; Cabaletta Bio; Cabaletta Bio; Chugai Pharma; crispr therapeutics; GlaxoSmithKline; In8Bio; In8bio; Intellia Therapeutics; Kite, a Gilead company; MicroMedicine; Novartis; Oncternal Therapeutics; Sanofi; TCR2 Therapeutics; Tmunity Therapeutics, Inc.; Torque; windmil

Research Funding - Kite, a Gilead company (Inst); Moderna Therapeutics (Inst); Servier (Inst); Sobi (Inst)

Patents, Royalties, Other Intellectual Property - Inventor on patents held by Massachusetts General Hospital/Partners Health care; all related to CAR T cells and/or gene therapy; Inventor on patents held by U. Pennsylvania with and without Novartis

Marco  Davila

Stock and Other Ownership Interests  - A2 Biotherapeutics; Adaptive Biotechnologies; Adicet Bio

Honoraria - Poseida Therapeutics

Consulting or Advisory Role - A2 Biotherapeutics; Lyell Immunopharma

Speakers' Bureau - Bristol-Myers Squibb; Kite, a Gilead Company

Research Funding - Crispr Therapeutics

William  Go

Employment - A2 Biotherapeutics

Stock and Other Ownership Interests  - A2 Biotherapeutics

Kirstin  Liechty

Employment - A2 Biotherapeutics

Stock and Other Ownership Interests  - A2 Biotherapeutics

William  Bretzlaff

Employment - A2 Biotherapeutics

Stock and Other Ownership Interests  - A2 Biotherapeutics

Armen  Mardiros

Employment - A2 Biotherapeutics

Stock and Other Ownership Interests  - A2 Biotherapeutics

Antonious  Hazim

No Relationships to Disclose

Matthew  Ulrickson

Consulting or Advisory Role - ADC Therapeutics; Autolus; Bristol-Myers Squibb/Celgene/Juno; Genentech; Kura Oncology; Stemline Therapeutics

Research Funding - Immunogen; Kite, a Gilead company

Travel, Accommodations, Expenses - Miltenyi Biotec

Salman  Punekar

Research Funding - A2 Biotherapeutics (Inst); Affini-T Therapeutics (Inst); Amgen (Inst); Astellas Pharma (Inst); Constellation Pharmaceuticals (Inst); NCI (Inst); Neogene Therapeutics (Inst); Prelude Therapeutics (Inst); Revolution Medicines (Inst); Simcere (Inst); Tango Therapeutics (Inst); VITRAC Therapeutics (Inst)